AS
PCRX icon

Altshuler Shaham’s Pacira BioSciences PCRX Stock Holding History

Altshuler Shaham’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-469
Closed -$27K – 525
2022
Q2 		$27K Sell
469
-69
-13% -$4.52K ﹤0.01% 350
2022
Q1 		$41K Buy
+538
New +$35.9K ﹤0.01% 402
2020
Q4 		– Sell
-424
Closed -$25K – 448
2020
Q3 		$25K Buy
424
+17
+4% +$988 ﹤0.01% 308
2020
Q2 		$21K Buy
+407
New +$17K ﹤0.01% 259

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Altshuler Shaham's PCRX Position: Q3 2022 in Review

Altshuler Shaham sold out of Pacira BioSciences (PCRX) in Q3 2022, closing a stake of 469 shares — an estimated $27K sold.

Altshuler Shaham first reported a position in PCRX in Q2 2020 and held it in 4 quarters. The position peaked at $41K in Q1 2022. 273 funds tracked by Wall St. Rank hold PCRX as of Q3 2022.

  • Altshuler Shaham reported no remaining Pacira BioSciences position as of Q3 2022 after selling out during the quarter.
  • Altshuler Shaham sold 469 Pacira BioSciences shares in Q3 2022, an estimated $27K.
  • Altshuler Shaham first reported a position in Pacira BioSciences in Q2 2020 and held it in 4 quarters.
  • Altshuler Shaham's Pacira BioSciences position peaked at $41K in Q1 2022.
  • 273 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2022.

Based on Altshuler Shaham's 13F filing for Q3 2022, filed 14 Nov 2022.